Join today

ai4pa
Artificial Intelligence For Patient Advocates

An introduction to transparent and explainable AI and its policy context.
Format

Online
Course

Starting date

any time

Live modules

coming soon

brought to you by

iToBoS

Duration

permanent

Price

free

What you are going to learn

AI for patient advocates 

Important concepts and policy context.
iTOBOS module I

Throughout this learning module you will:

  • cover the concepts of machine learning, artificial intelligence
  • understand what transparent and explainable AI is
  • get an overview of the current policy context, with focus on the EU


This module was developed for the iTBoBoS by MPNE with members of the iToBoS consortium and external faculty. 
iToBoS is funded by the European Union's Horizon 2020 research and innovation programme under Grant Agreement 965221.

iToBoS 

intelligent Total Body Scanner for early detection of Melanoma
About
iToBoS is a research project funded by the European Union's Horizon 2020 research and innovation programme under Grant Agreement 965221. The project started 1 April 2021, has a duration of 48 months and a total budget of 12 million Euro.
iToBoS' scope is to train an Artificial Intelligence (AI) system that integrate information from different sources: dermoscopic images, complete medical records and genomics data to develop and validate a new diagnostic device. This device will, together with an AI cognitive assistant, allow healthcare practitioners to detect Melanoma early and with high accuracy. 
I
Find out more about iTOBOS here

Why patient advocates should know about
Artificial Intelligence 

"Patient advocates should care about AI because it will determine which patients are eligible for particular treatments, which treatment options are the most cost effective and therefore funded, and constrain life-choices for those same patients in almost all walks of life, from getting a loan to getting a job."
Rob White 
MPNE hub 
"Currently, major policy decisions are taken around AI. Patients advocates need to have an educated opinion - it directly affects their patient communities."
Bettina Ryll
MPNE founder